about
Novel Investigations of Flavonoids as Chemopreventive Agents for Hepatocellular CarcinomaEvaluation of antiangiogenic efficacy in advanced hepatocellular carcinoma: Biomarkers and functional imagingAlteration of Epigenetic Profile in Human Hepatocellular Carcinoma and Its Clinical ImplicationsTargeting p110gamma in gastrointestinal cancers: attack on multiple frontsHepatocellular carcinoma: Consensus, controversies and future directions. A report from the Canadian Association for the Study of the Liver Hepatocellular Carcinoma MeetingTreatment of hepatocellular carcinoma: Steps forward but still a long way to goDrug therapy for advanced-stage liver cancerChemotherapeutic agents for the treatment of hepatocellular carcinoma: efficacy and mode of actionBaicalein induces apoptosis and autophagy via endoplasmic reticulum stress in hepatocellular carcinoma cellsRole of antiviral therapy in reducing recurrence and improving survival in hepatitis B virus-associated hepatocellular carcinoma following curative resection (Review)Treatment for hepatocellular carcinoma in Japan over the last three decades: Our experience and published work reviewGenome-Wide Expression of MicroRNAs Is Regulated by DNA Methylation in Hepatocarcinogenesis.Fucoidan Elevates MicroRNA-29b to Regulate DNMT3B-MTSS1 Axis and Inhibit EMT in Human Hepatocellular Carcinoma CellsAnaplastic lymphoma kinase protein expression predicts micrometastases and prognosis for patients with hepatocellular carcinomaSorafenib in advanced hepatocellular carcinoma: current status and future perspectives.Nanoformulations for therapy of pancreatic and liver cancers.Advances in targeted therapies for hepatocellular carcinoma in the genomic era.Sorafenib-based combined molecule targeting in treatment of hepatocellular carcinoma.A new key player in VEGF-dependent angiogenesis in human hepatocellular carcinoma: dimethylarginine dimethylaminohydrolase 1.Single Agent and Synergistic Activity of the "First-in-Class" Dual PI3K/BRD4 Inhibitor SF1126 with Sorafenib in Hepatocellular Carcinoma.Fibroblast growth factor family as a potential target in the treatment of hepatocellular carcinoma.Vertical Targeting of AKT and mTOR as Well as Dual Targeting of AKT and MEK Signaling Is Synergistic in Hepatocellular Carcinoma.NRAS mutations in cutaneous T cell lymphoma (CTCL) sensitize tumors towards treatment with the multikinase inhibitor Sorafenib.A Surgical Perspective on Targeted Therapy of Hepatocellular Carcinoma.Synthetic lethal interaction of combined CD26 and Bcl-xL inhibition is a powerful anticancer therapy against hepatocellular carcinoma.Role of nonresolving inflammation in hepatocellular carcinoma development and progression.
P2860
Q26767372-6AC84FC9-65C3-46BA-93BB-AC6239EB87E2Q26783895-E4D5519B-E676-47D2-A4C9-BDF94D77F3F2Q26797616-41D9CD91-050C-43C3-A4AA-BDD7F938CBF3Q26823575-1FD1E861-AE77-45E8-82FB-80287A9E13B6Q26828407-EB25B354-33F0-47DB-9F7A-2E265D97608DQ26865456-0C444543-6F22-4A50-9862-114F90EA7543Q27004410-B872B55E-D850-490E-A74F-36AC7FF57B1EQ27693179-5A617417-533C-4F69-BFD8-F049746D164DQ33786747-8B5995A1-0C9C-40AA-A042-BD9B82B04E35Q34993924-22B1E785-BFC0-4F86-863C-65135B34FF0EQ35037545-BFA6B9FE-D058-4A2A-B730-A64C101A256AQ35227134-4DD74F83-07E6-44A4-859C-95C3033F6E19Q36226732-B97B0B16-0292-4DD8-A52A-434F116ADF81Q36502649-FF4A33BB-1A12-4170-B49A-254200D02238Q37031712-04133D0C-A1DC-476A-8325-158B67D6F832Q38495105-A4956F2D-3A4A-4DC7-A92F-7F367CD46B0BQ38521011-CFF9A42E-1433-40F8-BFDB-EE2291FF1B69Q38635603-133C8B33-E808-4BD6-8BA7-3CABDFA9EE2EQ38652256-BB41E551-B28A-4BFE-9C7D-C40BCE335E95Q38734040-C8705AE3-7A30-455C-8758-C51135F69A65Q38923517-D2F2C0AB-ACC8-42F3-8A65-07E6F4520AB1Q38946509-49FD6434-B32C-4C52-A68D-1DFCB979778DQ41233629-131824BA-4BFB-40E0-8B72-B9C43EA88091Q42064611-04026652-C98F-437E-BAA9-E9E5D7A99BF0Q52305766-EAD3BCA8-C333-4AD2-9849-855C4EB87E96Q55288642-746776FF-E8DC-4F3B-A7C2-EEA7824D4B91
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical trials in hepatocellular carcinoma: an update.
@en
Clinical trials in hepatocellular carcinoma: an update.
@nl
type
label
Clinical trials in hepatocellular carcinoma: an update.
@en
Clinical trials in hepatocellular carcinoma: an update.
@nl
prefLabel
Clinical trials in hepatocellular carcinoma: an update.
@en
Clinical trials in hepatocellular carcinoma: an update.
@nl
P2093
P2860
P356
P1433
P1476
Clinical trials in hepatocellular carcinoma: an update.
@en
P2093
Ann-Lii Cheng
Chih-Hung Hsu
Ying-Chun Shen
Yu-Yun Shao
Zhong-Zhe Lin
P2860
P304
P356
10.1159/000343850
P577
2013-08-01T00:00:00Z